{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:27:47Z","timestamp":1777501667390,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.hjc.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T12:59:48Z","timestamp":1547038788000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Challenges and unanswered questions in STEMI management"],"prefix":"10.1016","volume":"60","author":[{"given":"Athanasios","family":"Koutsoukis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Kanakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2019.01.001_bib1","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/eurheartj\/ehx515","article-title":"Improved outcomes in patients with st-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDHEART registry 1995-2014","volume":"38","author":"Szummer","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hjc.2019.01.001_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J [Internet]"},{"issue":"12","key":"10.1016\/j.hjc.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.resuscitation.2012.08.337","article-title":"Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest: a systematic review and meta-analysis","volume":"83","author":"Larsen","year":"2012","journal-title":"Resuscitation"},{"issue":"8","key":"10.1016\/j.hjc.2019.01.001_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehp492","article-title":"Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries","volume":"31","author":"Widimsky","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2019.01.001_bib5","doi-asserted-by":"crossref","first-page":"P116","DOI":"10.4244\/EIJV8SPA20","article-title":"Stent for life initiative - the greek experience","volume":"8","author":"Kanakakis","year":"2012","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.hjc.2019.01.001_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.284.1.60","article-title":"Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart diseasethe Rapid Early Action for Coronary Treatment (REACT) trial","volume":"284","author":"Luepker","year":"2000","journal-title":"J\u00a0Am Med Assoc"},{"issue":"23","key":"10.1016\/j.hjc.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/CIRCULATIONAHA.111.018549","article-title":"Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase","volume":"124","author":"Pinto","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or primary pci in st-segment elevation myocardial infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2019.01.001_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","article-title":"Hausenloy DJ Reducing myocardial infarct size: challenges and future opportunities","volume":"102","author":"Bulluck","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.hjc.2019.01.001_bib10","article-title":"Ischemia-reperfusion injury: complex pathophysiology with elusive treatment","author":"Papageorgiou","year":"2018","journal-title":"Hell J Cardiol"},{"issue":"14","key":"10.1016\/j.hjc.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","article-title":"Effect of early metoprolol on infarct size in STsegment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2019.01.001_bib12","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early administration of intravenous beta-blockers in patients with st-elevation myocardial infarction before primary PCI","volume":"67","author":"Roolvink","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hjc.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jacc.2015.10.081","article-title":"Cyclosporine a in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE trial","volume":"67","author":"Ottani","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2019.01.001_bib14","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/eurheartj\/ehw136","article-title":"Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial","volume":"37","author":"Nazir","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hjc.2019.01.001_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/joic.12485","article-title":"Effects of endovascular cooling on infarct size in ST-segment elevation myocardial infarction: a patient-level pooled analysis from randomized trials","volume":"31","author":"Dae","year":"2018","journal-title":"J\u00a0Intervent Cardiol"},{"key":"10.1016\/j.hjc.2019.01.001_bib16","article-title":"Effect of intravascular cooling on microvascular obstruction (MVO) in conscious patients with ST-elevation myocardial infarction undergoing primary PCI: Results from the COOL AMI EU pilot study","author":"Keeble","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.hjc.2019.01.001_bib17","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(16)30072-1","article-title":"Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): An open-label, randomised controlled trial","volume":"387","author":"Kelbaek","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hjc.2019.01.001_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa1808788","article-title":"One-year outcomes after PCI strategies in cardiogenic shock","volume":"379","author":"Thiele","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.hjc.2019.01.001_bib20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2019.01.001_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in st-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hjc.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.117.005528","article-title":"No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment\u21d3elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"11","author":"Koul","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4244\/EIJ-D-17-00852","article-title":"The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for st-elevation myocardial infarction: a systematic review and meta-analysis","volume":"14","author":"Bellemain-Appaix","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hjc.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4244\/EIJV14I1A3","article-title":"P2Y12 inhibition in STEMI: early, strong or both?","volume":"14","author":"Mangiacapra","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hjc.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2015.05.064","article-title":"Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: ready for prime time?","volume":"194","author":"Alexopoulos","year":"2015","journal-title":"Int J Cardiol Netherlands"},{"issue":"5","key":"10.1016\/j.hjc.2019.01.001_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamacardio.2018.0644","article-title":"The TREAT trial\u2014moving st-elevation myocardial infarction care forward, with more to do","volume":"3","author":"Yancy","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hjc.2019.01.001_bib27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after pci in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2019.01.001_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2018.03.001","volume":"200","author":"Lopes","year":"2018","journal-title":"Am Heart J United States"},{"key":"10.1016\/j.hjc.2019.01.001_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ahj.2017.10.009","article-title":"Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial","volume":"196","author":"Vranckx","year":"2018","journal-title":"Am Heart J United States"},{"key":"10.1016\/j.hjc.2019.01.001_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.118.034722","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention","volume":"138","author":"Angiolillo Dominick","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2019.01.001_bib31","first-page":"8","article-title":"Health-related quality of life after adverse bleeding events associated with antithrombotic drug therapy \u2013 a systematic review","author":"Res","year":"2018","journal-title":"Hell J Cardiol [Internet]"},{"key":"10.1016\/j.hjc.2019.01.001_bib32","article-title":"An open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond one year after coronary stent implantation: the OAC-ALONE study","author":"Matsumura-Nakano","year":"2018","journal-title":"Circulation"},{"issue":"41","key":"10.1016\/j.hjc.2019.01.001_bib33","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2019.01.001_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable cardioverter defibrillator after myocardial infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hjc.2019.01.001_bib35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9994","key":"10.1016\/j.hjc.2019.01.001_bib36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3\u2014PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstr\u00f8m","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2019.01.001_bib37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional flow reserve guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2019.01.001_bib38","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.jcin.2017.07.021","article-title":"Nonculprit stenosis evaluation using instantaneous wave-free ratio in patients with st-segment elevation myocardial infarction","volume":"10","author":"Thim","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hjc.2019.01.001_bib39","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"B-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hjc.2019.01.001_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamainternmed.2018.0514","article-title":"Sex differences in outcomes after STEMI: effect modification by treatment strategy and age","volume":"178","author":"Cenko","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"10.1016\/j.hjc.2019.01.001_bib41","first-page":"1","article-title":"Outcome of 1051 octogenarian patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: Observational cohort from the London heart attack group","volume":"5","author":"Bromage","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"24","key":"10.1016\/j.hjc.2019.01.001_bib42","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"CRUSADE investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of nonST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.hjc.2019.01.001_bib43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.hjc.2019.01.001_bib44","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2019.01.001_bib45","first-page":"E202","volume":"87","author":"Iliescu","year":"2016","journal-title":"Cathet Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.hjc.2019.01.001_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.mayocp.2016.06.029","article-title":"Cancer history portends worse acute and long-term noncardiac (but not cardiac) mortality after primary percutaneous coronary intervention for acute st-segment elevation myocardial infarction","volume":"91","author":"Wang","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.hjc.2019.01.001_bib47","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2003.07.017","article-title":"A\u00a0randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction","volume":"42","author":"Antoniucci","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966618305360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966618305360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:12:21Z","timestamp":1761099141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966618305360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1109966618305360"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2019.01.001","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and unanswered questions in STEMI management","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}